Enhance: A multi-centre, randomised phase IV study

Project Details

Introduction: This collaborative study compares newer formulations of oxycodone across different settings for people with cancer

Title - Enhance: A multi-centre, randomised, phase IV study to compare the efficacy of oxycodone/naloxone verses oxycodone prolonged release tablets in patients with advanced cancer

Key Aim To evaluate two pain relief medications, oxycodone/naloxone prolonged-release (OXN PR) and oxycodone alone prolonged-release (Oxy PR) with respect to analgesic efficacy and constipation in patients with advanced cancer.

Further Information: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377673&isReview=true

Researchers

Principal Investigator: Dr Aaron Wong, Peter MacCallum Cancer Centre (Aaron.wong@petermac.org)

Collaborators

Mundipharma

Funding

Mundipharma

Research Group

Palliative Nexus



Faculty Research Themes

Cancer

School Research Themes

Cancer in Medicine



Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Medicine and Radiology

Node

St Vincent's Hospital

MDHS Research library
Explore by researcher, school, project or topic.